Kalshi was hit by an outage right as the early slate of college football games reached their conclusion and mid-afternoon ...
8hon MSNOpinion
Editorial: More thought needed on JIP's 'second capital' plan to form 'Osaka metropolis'
The ruling Liberal Democratic Party (LDP) and Nippon Ishin (the Japan Innovation Party, JIP) have agreed to legislate a plan ...
Opinion
MedPage Today on MSNSpotting Trends in Patients' Tests
Statistics, and the standard deviation of our tests, mean that if you order a complete metabolic profile, a lipid panel, a ...
In four preseason games, the Pacers established top four players were excellent, but their depth was depleted by injuries. On ...
Live Science on MSN
Quantum computing 'lie detector' finally proves these machines tap into Einstein's spooky action at a distance rather than just faking it
While quantum phenomena can be demonstrated using experiments such as the Double-Slit Experiment, certifying that a multi-qubit system is truly tapping into quantum mechanics is a challenge. It also ...
The government shutdown is now tied for the second-longest federal work stoppage in US history after 21 days — and 11 failed ...
An International Atomic Energy Agency (IAEA) team of experts has found that Hungary demonstrates a strong commitment to nuclear and radiation safety. The team’s review, held from 6 to 17 October, ...
DIH Holding US, Inc. ('DIH” or the 'Company”) (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive ...
3hon MSN
Goldman Sachs CEO David Solomon says there's a key difference between AI and past job revolutions
The rise of AI is a lot like other tech revolutions, just a lot quicker, Goldman Sachs CEO David Solomon says.
The new GTS lives below the Turbo in the Macan EV lineup and comes standard with an electronic limited-slip differential.
Porsche may be easing off its plans of having 80 percent of its lineup electric by 2030, but it’s hardly abandoning the ...
The Food and Drug Administration (FDA) has approved Gazyva ® (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results